The Patent Finder

Helsinki University Licensing, Ltd.

Also on record
Records under this name other than patents Helsinki University Licensing, Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Helsinki University Licensing, Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,976,934Shift Control System for Hybrid Vehicles
Formerly held
Term ended
Term ended Jan 16, 2024 · High confidence
Term endedTerm ended Jan 16, 2024High confidence
US 6,795,178Method and apparatus for analysis of gas compositions
Term ended
Term ended Dec 6, 2020 · USPTO record
Term endedTerm ended Dec 6, 2020USPTO record
US 6,706,687Platelet-derived growth factor D
Formerly held
Term ended
Term ended Nov 10, 2019 · USPTO record
Term endedTerm ended Nov 10, 2019USPTO record
US 7,410,639Vascular endothelial growth factor D(VEGF-D) antibodies and methods of use
Formerly held
Term ended
Term ended Mar 21, 2019 · USPTO record
Term endedTerm ended Mar 21, 2019USPTO record
US 7,947,472Expression vectors and cell lines expressing vascular endothelial growth factor D
Formerly held
Term ended
Ended no later than Dec 23, 2018 · USPTO record
Term endedEnded no later than Dec 23, 2018USPTO record
US 7,122,654Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use
Formerly held
Term ended
Term ended Sep 14, 2018 · USPTO record
Term endedTerm ended Sep 14, 2018USPTO record
US 6,331,301Antibodies specific for vascular endothelial growth factor-B
Term ended
Term ended May 6, 2017 · USPTO record
Term endedTerm ended May 6, 2017USPTO record
US 6,432,635Cystatin B mutants
Term ended
Term ended Mar 18, 2017 · USPTO record
Term endedTerm ended Mar 18, 2017USPTO record
US 6,130,071Vascular endothelial growth factor C (VEGF-C) .DELTA.Cys.sub.156 protein and gene, and uses thereof
Formerly held
Term ended
Term ended Feb 5, 2017 · USPTO record
Term endedTerm ended Feb 5, 2017USPTO record
US 6,361,946Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
Formerly held
Term ended
Term ended Feb 5, 2017 · USPTO record
Term endedTerm ended Feb 5, 2017USPTO record
10 of 35 patents shown.
Pro members see all 35.
Pro members: see all 35 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited